Intestinal anti‐tissue transglutaminase antibodies in potential coeliac disease

Anti‐tissue transglutaminase 2 (anti‐TG2) antibodies are present in the serum of the great majority of untreated coeliac disease (CD) patients. They are produced and deposited in the small intestinal mucosa. Potential CD patients present serum anti‐TG2 antibodies higher than cut‐off, but a normal duodenal mucosa where mucosal deposits of anti‐TG2 are not always detectable. The aim of our work was to investigate the presence of anti‐TG2 intestinal antibodies in patients with potential CD, and identify the most sensitive test to detect them. Twelve active CD patients, 28 potential CD patients and 39 non‐CD controls were enrolled. Biopsy fragments from all patients were analysed by double immunofluorescence to detect mucosal deposits of anti‐TG2 antibodies. Fragments from the same subjects were also cultured for 24 h with medium in the presence or absence of gliadin peptides. Anti‐TG2 autoantibodies secreted into supernatants were measured by enzyme‐linked immunosorbent assay. All active CD, 68% of potential CD patients and 20% of non‐CD controls showed mucosal deposits of immunoglobulin (Ig)A anti‐TG2; at the same time 100, 96 and 8% of active CD, potential CD and non‐CD control patients secreted these antibodies in culture supernatants, respectively. Our data showed that, to detect intestinal anti‐TG2 antibodies, the measurement of antibodies secreted into culture supernatants has higher sensitivity and specificity (97·5 and 92·3%, respectively) than the detection of mucosal deposits (77·5 and 80·0%, respectively). The measurement of intestinal anti‐TG2 antibodies may prove useful in clinical practice to predict evolution towards mucosal atrophy in potential coeliac patients and identify patients with gluten sensitivity.

[1]  F. Tovoli,et al.  Serological Tests in Gluten Sensitivity (Nonceliac Gluten Intolerance) , 2012, Journal of clinical gastroenterology.

[2]  D. Sanders,et al.  The Oslo definitions for coeliac disease and related terms , 2012, Gut.

[3]  L. Ronfani,et al.  Accuracy of Diagnostic Antibody Tests for Coeliac Disease in Children: Summary of an Evidence Report , 2012, Journal of pediatric gastroenterology and nutrition.

[4]  L. Sollid,et al.  Abundance and unique repertoire of plasma cells secreting IgA autoantibodies to transglutaminase 2 in the intestinal lesion of celiac disease , 2012, Nature Medicine.

[5]  K. Giersiepen,et al.  European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease , 2012, Journal of pediatric gastroenterology and nutrition.

[6]  F. Paparo,et al.  Intestinal deposits of anti-tissue transglutaminase IgA in childhood celiac disease. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[7]  R. Troncone,et al.  Coeliac disease and gluten sensitivity , 2011, Journal of internal medicine.

[8]  R. Marzari,et al.  Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet , 2011, Gut.

[9]  L. Greco,et al.  Natural history of potential celiac disease in children. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  M. Di Tola,et al.  Organ culture system as a means to detect celiac disease. , 2010, Annals of clinical and laboratory science.

[11]  F. Paparo,et al.  Majority of Children With Type 1 Diabetes Produce and Deposit Anti-Tissue Transglutaminase Antibodies in the Small Intestine , 2009, Diabetes.

[12]  A. Sannino,et al.  Immunoglobulin A Anti-tissue Transglutaminase Antibody Deposits in the Small Intestinal Mucosa of Children With No Villous Atrophy , 2008, Journal of pediatric gastroenterology and nutrition.

[13]  K. Kaukinen,et al.  Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits , 2008, BMC Immunology.

[14]  M. Zeitz,et al.  Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  K. Kaukinen,et al.  Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease , 2006, Alimentary pharmacology & therapeutics.

[16]  C. Scalici,et al.  Anti-transglutaminase antibody assay of the culture medium of intestinal biopsy specimens can improve the accuracy of celiac disease diagnosis. , 2006, Clinical chemistry.

[17]  M. Bardella,et al.  Usefulness of the organ culture system in the in vitro diagnosis of coeliac disease: a multicentre study. , 2006, Scandinavian journal of gastroenterology.

[18]  L. Lorand,et al.  Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits , 2006, Gut.

[19]  S. Koletzko,et al.  Detection of secretory IgA antibodies against gliadin and human tissue transglutaminase in stool to screen for coeliac disease in children: validation study , 2005, BMJ : British Medical Journal.

[20]  I. Korponay-Szabó,et al.  In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies , 2004, Gut.

[21]  S Auricchio,et al.  An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients , 2003, Gut.

[22]  L. Sollid.  Coeliac disease: dissecting a complex inflammatory disorder , 2002, Nature Reviews Immunology.

[23]  G. Iacono,et al.  Production of Anti-Endomysial Antibodies in Cultured Duodenal Mucosa: Usefulness in Coeliac Disease Diagnosis , 2002, Scandinavian journal of gastroenterology.

[24]  S. Vetrano,et al.  Antiendomysial antibody detection in fecal supernatants: in vivo proof that small bowel mucosa is the site of antiendomysial antibody production , 2002, American Journal of Gastroenterology.

[25]  E. Tongiorgi,et al.  Molecular Dissection of the Tissue Transglutaminase Autoantibody Response in Celiac Disease1 , 2001, The Journal of Immunology.

[26]  G. Oberhuber,et al.  The histopathology of coeliac disease: time for a standardized report scheme for pathologists. , 1999, European journal of gastroenterology & hepatology.

[27]  G. Oberhuber,et al.  In vitro production of endomysial antibodies in cultured duodenal mucosa from patients with celiac disease , 1999, American Journal of Gastroenterology.

[28]  D. Schuppan,et al.  Identification of tissue transglutaminase as the autoantigen of celiac disease , 1997, Nature Medicine.

[29]  M. Greco,et al.  Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease , 1996, The Lancet.

[30]  A. Love,et al.  Anti-reticulin antibody in jejunal juice in coeliac disease. , 1975, Clinical and experimental immunology.